comparemela.com

Joel Portice News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Uncovering untreated heart disease with AI and data

Ancora Heart, Egnite partner on AccuCinch trial enrollment

Ancora Heart announced that it entered into a strategic partnership with Egnite to accelerate clinical trial enrollment.

Ancora Heart Inc and egnite, Inc Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure Patients

Ancora Heart Inc and egnite, Inc Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

egnite, Inc Expands into Cardiovascular Disease Supported by New Data on the State of Care for Patients with Atrial Fibrillation

Digital health company egnite launches with AI heart disease platform

Photo provided by egnite A new digital healthcare company called egnite launched Wednesday with the goal of leveraging advanced technologies and analytics to improve health outcomes for structural heart-disease patients. Egnite originates from the CardioCare platform developed by Edwards Lifesciences, which is already deployed at over 50 hospitals and health systems across the country. The platform is designed to manage patients with structural heart disease by using artificial intelligence to keep patients on track in their care journey, reduce diagnostic variability and streamline clinical workflows. Based on the adoption of its flagship product, egnite is launching with CardioCare in its portfolio and with plans to develop more digital solutions that harness data science to improve patient outcomes and reduce healthcare costs.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.